Investing Profile

Jason P. Hafler

InvestorVC
Managing Director at Sanofi Ventures
sanofiventures.com/team/index...Cambridge, Massachusetts
Photo of Jason P. Hafler, Managing Director at Sanofi Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Sanofi Ventures Managing Director
$5.0M - $10.0M
$7.5M
9
CompanyStageDateRound SizeTotal Raised
Star Therapeutics
Series DSep 2025$130M
$220M
Co-investors: Carl Gordon (OrbiMed), Maha Katabi (Sofinnova Investments), Beth Seidenberg (Westlake Village BioPartners)
Character Biosciences
Series BSep 2025$17M
$130M
Co-investors: Cain McClary (KdT Ventures), John Noonan (Lifeforce Capital), Jonathan Roosevelt (Industry Ventures), Joel Dudley (Innovation Endeavors), Milad Alucozai (BoxOne Ventures), Shane Neman
Abcuro
Series CFeb 2025$200M
Series AJan 2021$42M
$400M
Co-investors: Michele Park (New Enterprise Associates (NEA)), Tomer Kariv (Pontifax Venture Capital), Iyona Rajkomar (Pontifax Venture Capital)
Atalanta Therapeutics
Series BJan 2025$97M
$210M
Co-investors: Jessica Alston (F-Prime Capital Partners), Stacie Weninger (F-Prime Capital Partners), Stephen Knight (F-Prime Capital Partners), Niall O’Donnell (RiverVest)
Escient Pharmaceuticals
Series CNov 2022$120M
Series BSep 2020$78M
$240M
Co-investors: Andrew Schwab (5am Ventures), JeenJoo Kang (The Column Group)
Matchpoint Therapeutics
Series AOct 2022$70M
$100M
Co-investors: Bruce Booth (Atlas Venture), Dan Becker (Access Biotechnology)
NeuroVia
Series AJul 2017$14M
$14M